Literature DB >> 16493214

Treatment of urethral syndrome: a prospective randomized study with Nd:YAG laser.

Elisabetta Costantini1, Alessandro Zucchi, Michele Del Zingaro, Luigi Mearini.   

Abstract

INTRODUCTION: The urethral syndrome is characterized by irritative disturbances, the urgency-frequency syndrome and/or pain associated with negative urine cultures. Areas of metaplasic tissue in the trigonal-bladder neck region (trigonitis) are sometimes present. We performed a comparative randomized study to assess the efficacy of side- or end-firing neodymium (Nd):YAG laser surgery in destroying metaplasia and relieving symptoms.
MATERIALS AND METHODS: Between January 1997 and December 2003, 62 consecutive women with the urethral syndrome and squamous metaplasia of the bladder neck-trigone, who were refractory to drugs, were randomly assigned to treatment with end-firing (group A) or side-firing (group B) Nd:YAG laser. Three, 6 and 12 months after surgery all patients underwent a clinical urological examination and cystoscopy. Surgery was considered successful when patients reported they were satisfied with the outcome or stated on the UDI-6 questionnaire that symptoms were reduced by at least 75%.
RESULTS: Group A end-firing laser: patients rapidly improved (2-3 weeks) but symptoms worsened within 3 months. At 6-12 months, symptoms had improved in 19% of the 31 patients and remained unchanged or worsened in 81%. Group B side-firing laser: irritative disturbances worsened in the 7-10 days after therapy but markedly improved within 2-3 months. Symptoms significantly improved in 68% of the 28 patients and remained unchanged or worsened in 32%. Results were significantly better after side-firing laser (p < 0.001) and a trend towards improvements emerged as the joule levels rose. At 3 months, cystoscopy and biopsy showed squamous metaplasia was no longer present in patients whose symptoms had improved. Whitish areas were still present in the bladder neck-trigone in patients whose symptoms had remained unchanged or worsened. These patients were retreated.
CONCLUSIONS: In the treatment of the urethral syndrome the few reports on attempts to restore a normal urothelium by means of diathermocoagulation and cryotherapy have been encouraging. Side-firing laser, which produces necrotic coagulation followed by reconstitution of normal functional epithelium, was significantly more successful than end-firing and was associated with a 78% success rate. These results are encouraging in patients who are usually refractory to medical therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16493214     DOI: 10.1159/000090876

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  5 in total

1.  Immunohistochemical analysis of sex hormone receptors in squamous changes of the urothelium.

Authors:  Julia B Seitz; Josef Högel; Markus Eckstein; Verena Lieb; Bernd Wullich; Arndt Hartmann; Ralf J Rieker
Journal:  Int J Clin Exp Pathol       Date:  2022-07-15

2.  Interventions for treating people with symptoms of bladder pain syndrome: a network meta-analysis.

Authors:  Mari Imamura; Neil W Scott; Sheila A Wallace; Joseph A Ogah; Abigail A Ford; Yann A Dubos; Miriam Brazzelli
Journal:  Cochrane Database Syst Rev       Date:  2020-07-30

Review 3.  [Urethral pain syndrome: fact or fiction--an update].

Authors:  N M Dreger; S Degener; S Roth; A S Brandt; D A Lazica
Journal:  Urologe A       Date:  2015-09       Impact factor: 0.639

4.  Transurethral resection in women with symptomatic keratinizing squamous metaplasia of urinary bladder: A retrospective study of 92 cases.

Authors:  Huan Wang; Tie Chong; Xiu-Ying Tang; Wen-Bo Zheng
Journal:  Low Urin Tract Symptoms       Date:  2019-11-24       Impact factor: 1.592

5.  Treatment of Urethral Pain Syndrome (UPS) in Sweden.

Authors:  Lina Birgitta Ivarsson; Björn Erik Lindström; Matts Olovsson; Annika Kristina Lindström
Journal:  PLoS One       Date:  2019-11-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.